WuXi NextCODE has struck another sequencing agreement. The latest deal will see the service provider sequence samples taken from 1,000 cancer patients in San Antonio, TX. Phase I clinical trial specialist South Texas Accelerated Research Therapeutics plans to link the genome data to patient records using Medidata ($MDSO) Rave, before making the resource available to researchers and clinicians. Release | Article